Literature DB >> 27596524

Long-term exposures to low doses of silver nanoparticles enhanced in vitro malignant cell transformation in non-tumorigenic BEAS-2B cells.

Wun Hak Choo1, Cho Hee Park2, Shi Eun Jung2, Byeonghak Moon2, Huiyeon Ahn2, Jung Seok Ryu3, Keun-Soo Kim4, Yong Hwa Lee5, Il Je Yu2, Seung Min Oh6.   

Abstract

To predict carcinogenic potential of AgNPs on the respiratory system, BEAS-2B cells (human bronchial epithelial cells) were chronically exposed to low- and non-cytotoxic dose (0.13 and 1.33μg/ml) of AgNPs for 4months (#40 passages). To assess malignant cell transformation of chronic exposure to AgNPs, several bioassays including anchorage independent agar colony formation, cell migration/invasion assay, and epithelial-mesenchymal transition (EMT) were performed in BEAS-2B cells. Chronic exposure to AgNPs showed a significant increase of anchorage independent agar colony formation and cell migration/invasion. EMT, which is the loss of epithelial markers (E-Cadherin and Keratin) and the gain of mesenchymal marker (N-cadherin and Vimentin), was induced by chronic exposure to AgNPs. These responses indicated that chronic exposure to AgNPs could acquire characteristics of tumorigenic cells from normal BEAS-2B cells. In addition, caspase-3, p-p53, p-p38, and p-JNK were significantly decreased, while p-ERK1/2 was significantly increased. MMP-9 related to cell migration/invasion was upregulated, while a MMP-9 inhibitor, TIMP-1 was down-regulated. These results indicated that BEAS-2B cells exposed to AgNPs could induce anti-apoptotic response/anoikis resistance, and cell migration/invasion by complex regulation of MAPK kinase (p38, JNK, and ERK) and p53 signaling pathways. Therefore, we suggested that long-term exposure to low-dose of AgNPs could enhance malignant cell transformation in non-tumorigenic BEAS-2B cells. Our findings provide useful information needed to assess the carcinogenic potential of AgNPs.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; BEAS-2B cells; Chronic exposure; Malignant cell transformation; Metastasis; Silver nanoparticles

Mesh:

Substances:

Year:  2016        PMID: 27596524     DOI: 10.1016/j.tiv.2016.09.003

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  8 in total

1.  The Effects of Genotype × Phenotype Interactions on Transcriptional Response to Silver Nanoparticle Toxicity in Organotypic Cultures of Murine Tracheal Epithelial Cells.

Authors:  Tyler P Nicholas; Anoria K Haick; Theo K Bammler; Tomomi W Workman; Terrance J Kavanagh; Elaine M Faustman; Sina A Gharib; William A Altemeier
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

2.  Low-Dose Silver Nanoparticle Surface Chemistry and Temporal Effects on Gene Expression in Human Liver Cells.

Authors:  John S House; Evangelia Bouzos; Kira M Fahy; Victorino Miguel Francisco; Dillon T Lloyd; Fred A Wright; Alison A Motsinger-Reif; Prashanth Asuri; Korin E Wheeler
Journal:  Small       Date:  2020-03-29       Impact factor: 13.281

3.  Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma.

Authors:  Delong Jiao; Chun-Kwok Wong; Miranda Sin-Man Tsang; Ida Miu-Ting Chu; Dehua Liu; Jing Zhu; Man Chu; Christopher Wai-Kei Lam
Journal:  Sci Rep       Date:  2017-05-12       Impact factor: 4.379

4.  RNA-sequencing reveals long-term effects of silver nanoparticles on human lung cells.

Authors:  Anda R Gliga; Sebastiano Di Bucchianico; Jessica Lindvall; Bengt Fadeel; Hanna L Karlsson
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

5.  Iron oxide nanoparticles induce reversible endothelial-to-mesenchymal transition in vascular endothelial cells at acutely non-cytotoxic concentrations.

Authors:  Tao Wen; Lifan Du; Bo Chen; Doudou Yan; Aiyun Yang; Jian Liu; Ning Gu; Jie Meng; Haiyan Xu
Journal:  Part Fibre Toxicol       Date:  2019-07-12       Impact factor: 9.400

Review 6.  Toxicologic Concerns with Current Medical Nanoparticles.

Authors:  Tsai-Mu Cheng; Hsiu-Yi Chu; Haw-Ming Huang; Zi-Lin Li; Chiang-Ying Chen; Ya-Jung Shih; Jacqueline Whang-Peng; R Holland Cheng; Ju-Ku Mo; Hung-Yun Lin; Kuan Wang
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

7.  Morphological transformation induced by silver nanoparticles in a Balb/c 3T3 A31-1-1 mouse cell model to evaluate in vitro carcinogenic potential.

Authors:  Wunhak Choo; Byeonghak Moon; Sulhwa Song; Seung Min Oh
Journal:  Environ Health Toxicol       Date:  2017-10-07

Review 8.  Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment.

Authors:  Marco Cordani; Raffaele Strippoli; Álvaro Somoza
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.